The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model;Deneysel Tavşan Subaraknoid Kanama Modelinde İntravenöz Cilostazol ve Nimodipine Etkilerinin Araştirilmasi

Turkish Neurosurgery

Volumn 19, Issue 4, 2009, Pages 374-379

  Bilginer, Burcak ^a   Onal, Mehmet Bulent ^a   Narin, Firat ^a   Soylemezoglu, Figen ^a   Ziyal, Ibrahim M ^a   Ozgen, Tuncalp ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Basilar artery; Cerebral vasospasm; Cilostazol; Nimodipine; Subarachnoid hemorrhage

Indexed keywords

CILOSTAZOL; NIMODIPINE; TETRAZOLE DERIVATIVE; VASODILATOR AGENT;

ANIMAL; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; DISEASE MODEL; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOLOGY; RABBIT; SUBARACHNOID HEMORRHAGE;

ANIMALS; BASILAR ARTERY; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; INJECTIONS, INTRAVENOUS; MALE; NIMODIPINE; RABBITS; SUBARACHNOID HEMORRHAGE; TETRAZOLES; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 77449156530     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bilginer B, Onal B, Yigitkanli K, Soylemezoglu F, Bavbek M, Ziyal I.M, Ozgen T: Treatment of cerebral vasospasm with cilostazol in subarachnoid haemorrhage model. Acta Neurochir Suppl 104: 291-296,2008
2. Birk S, Edvinsson L, Olesen J, Kruuse C: Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries. Eur J Pharmacol 489(1-2):93-100,2004
3. Birk S, Kruuse C, Petersen KA, Jonassen O, Tfelt-Hansen P, Olesen J: The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab 24(12):1352-1358,2004
4. Choi JM, Shin HK, Kim KY, Lee JH, Hong KW: Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther 300(3):787-793,2002
5. Chow M, Dumont AS, Kassell NF: Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 51(6):1333-1341,2002
6. Clark J, Sharp F: Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26:1223-1233,2006
7. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schütt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P, Hennerici M: Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 70(4):534-537,2001
8. Firat MM, Gelebek V, Orer HS, Belen D, Firat AK, Balkanci F: Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. AJNR Am J Neuroradiol 26(6):1357-1362,2005
9. Hänggi D, Turowski B, Beseoglu K, Yong M, Steiger HJ: Intraarterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Influence on clinical course and cerebral perfusion. AJNR Am J Neuroradiol 29(6):1053-1060,2008
10. Hashimoto A, Miyakoda G, Hirose Y, Mori T: Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A-and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189(2):350-357,2006
11. Ito H, Miyakoda G, Mori T: Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation. Platelets 15(5):293-301,2004
12. Kambayashi J, Liu Y, Sun B, Shakur Y, Yoshitake M, Czerwiec F: Cilostazol as a unic antithrombotic agent. Curr Pharm Des 9: 2289-2302,2003
13. Kassell NF, Sasaki T, Colahan AR, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16(4):562-572,1985
14. Kim KY, Shin HK, Choi JM, Hong KW: Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. J Pharmacol Exp Ther 300(2):709-715,2002
15. Kimura Y, Tani T, Kanbe T, Watanabe K: Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneim Forsch 35:1144-1149,1985
16. Kohda N, Tani T, Nakayama S, Adachi T, Marukawa K, Ito R, Ishida K, Matsumoto Y, Kimura Y: Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. Thromb Res 96(4):261-8,1999
17. Liu Y, Fong M, Cone J, Wang S, Yoshitake M, Kambayashi J: Inhibition of adenosine uptake and augmentation of ischemia-induced increase of interstitial adenosine by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol 36(3):351-360, 2000
18. Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J: Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med 34(5):932-938,2008
19. Masaki T: The endothelin family: An overview. J Cardiovasc Pharmacol 35(4 Suppl. 2):3-5,2000
20. Minami N, Suzuki Y, Yamamoto M, Kihira H, Imai E, Wada H, Kimura Y, Ikeda Y, Shiku H, Nishikawa M: Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo. Life Sci 61(25):383-389,1997
21. Pluta RM: Delayed cerebral vasospasm and nitric oxide: Review, new hypothesis, and proposed treatment. Pharmacol Ther 101(1):23-56,2005
22. Pyne-Geithman GJ, Morgan CJ, Wagner K, Dulaney EM, Carrozzella J, Kanter DS, Zuccarello M, Clark JF: Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 25(8):1070-1077,2005
23. Sehba FA, Schwartz AY, Chereshnev I, Bederson JB: Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J Cereb Blood Flow Metab 20(3):604-611,2000
24. Tamai Y, Takami H, Nakahata R, Ono F, Munakata A: Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus. Haemostasis 29(5):269-276,1999
25. Tanaka K, Gotoh F, Fukuuchi Y, Amano T, Uematsu D, Kawamura J, Yamawaki T, Itoh N, Obara K, Muramatsu K: Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia. Stroke 20(5):668-673,1989
26. Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F: Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens 30(8):744-766,2008